28 March 2022
Diadem SpA, a company developing the first blood-based test for the early prediction of Alzheimer’s disease, announced the closing of the first tranche of a €10 million equity financing. The financing round is led by new investor CDP Venture Capital and existing investor Panakès Partners. The new funding follows the announcement earlier this month by Diadem and the European Investment Bank (EIB) that EIB has granted Diadem a €7.5 million venture loan.